九州通：12月19日召开董事会会议

Core Viewpoint - Jiuzhoutong (SH 600998) announced its sixth board meeting on December 19, 2025, to discuss the comprehensive credit application for 2026 [1] Group 1: Company Financials - For the first half of 2025, Jiuzhoutong's revenue composition was as follows: pharmaceutical wholesale and related businesses accounted for 95.94%, pharmaceutical manufacturing for 1.96%, pharmaceutical retail for 1.84%, healthcare and technology services for 0.17%, and other businesses for 0.08% [1] - As of the report date, Jiuzhoutong's market capitalization was 26.1 billion yuan [1]